Company news

Schrodinger, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Schrödinger to Announce First Quarter 2022 Financial Results on May 4

April 19, 2022

Schrödinger Reports New Preclinical Data Supporting Advancement of Its Wee1 Inhibitor Program at American Association of Cancer Research 2022 Annual Meeting

April 11, 2022

Schrödinger To Present New Preclinical Data From Its Wee1 Inhibitor Program At AACR Annual Meeting 2022

March 7, 2022

Schrödinger to Present at Truist Securities Life Sciences AI Symposium - Biotech & Tools

February 27, 2022

Schrödinger Reports Financial Results for the Fourth Quarter and Full Year 2021

February 23, 2022

Schrödinger to Announce Fourth Quarter and Full-Year 2021 Financial Results on February 24

February 9, 2022

Schrödinger to Present at SVB Leerink Virtual 11th Annual Global Healthcare Conference

February 7, 2022

Schrödinger Announces Acquisition of XTAL BioStructures, Inc.

January 17, 2022

Schrödinger to Present at H.C. Wainwright BioConnect Conference

January 4, 2022

Schrödinger Announces Retirement of Chief Financial Officer Joel Lebowitz

December 20, 2021

Schrödinger Reports Preclinical Data Supporting Advancement Of Its MALT1 Inhibitor Program At American Society Of Hematology 2021 Annual Meeting

December 10, 2021

Schrödinger to Participate in Five Upcoming Investor Conferences

November 21, 2021

Schrödinger Awarded Grant to Accelerate Drug Discovery in Women’s Health

November 17, 2021

Schrödinger Reports Third Quarter 2021 Financial Results and Provides Company Update

November 9, 2021

Schrödinger to Present New Preclinical Data From Its MALT1 Inhibitor Program at ASH 2021 Annual Meeting

November 3, 2021

Schrödinger to Host Conference Call to Discuss Third Quarter 2021 Financial Results

October 28, 2021

Centessa Pharmaceuticals Subsidiary, Orexia Therapeutics, and Schrödinger Announce Collaboration to Discover Novel Orexin Receptor Agonists

October 17, 2021

MD Anderson and Schrödinger Announce Strategic Research Collaboration to Accelerate Development of WEE1 Program

October 6, 2021

Schrödinger to Present at Four Investor Conferences in September

September 2, 2021

Schrödinger Reports Second Quarter 2021 Financial Results and Provides Company Update

August 11, 2021

Schrödinger and Zai Lab Announce a Global R&D Collaboration in Oncology

August 3, 2021

Schrödinger to Host Conference Call to Discuss Second Quarter 2021 Financial Results

July 29, 2021

Schrödinger Hosts First Annual Educator’s Day and Announces “Teaching with Schrödinger” Program

July 27, 2021

Schrödinger to Present at Two Virtual Investor Conferences in July

July 13, 2021

Schrödinger to Present at Two Investor Healthcare Conferences in June

May 24, 2021

Schrödinger Reports First Quarter 2021 Financial Results and Provides Company Update

May 10, 2021

Schrödinger to Present at the Bank of America Securities 2021 Virtual Healthcare Conference

May 3, 2021

Schrödinger to Host Conference Call to Discuss First Quarter 2021 Financial Results

April 26, 2021

Schrödinger Reports Preclinical Data on Novel, Selective CDC7 Inhibitors Presented at American Association for Cancer Research Annual Meeting

April 11, 2021

Schrödinger to Participate in BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery

April 8, 2021

Schrödinger to Host Webcast in Conjunction with Presentation of Preclinical Data for Its CDC7 Program at Virtual AACR Annual Meeting

March 29, 2021

Schrödinger to Participate in Credit Suisse 2021 Healthcare Innovators Series: The Intersection of Drug Discovery, Drug Development and Artificial Intelligence

March 16, 2021

Schrödinger Announces Preclinical Data for CDC7 Program to Be Presented at AACR Virtual Annual Meeting 2021

March 9, 2021

Schrödinger Reports Financial Results for the Fourth Quarter and Full Year 2020 and Provides Outlook for 2021

March 3, 2021

Schrödinger to Present at the H.C. Wainwright Global Life Sciences Conference

February 28, 2021

Schrödinger Expands Agreement with Google Cloud to Further Bolster Its Drug Discovery and Materials Science Initiatives

February 24, 2021

Schrödinger to Present at the SVB Leerink Partners 10th Annual Global Healthcare Conference

February 18, 2021

Schrödinger to Host Conference Call to Discuss Fourth Quarter and Year-End 2020 Financial Results

February 17, 2021

Schrödinger Presents Data from Its MALT1 Inhibitor Program at the American Society of Hematology (ASH) 2020 Annual Meeting

December 6, 2020

Schrödinger Announces a Multi-Target Drug Discovery, Development, and Commercialization Collaboration with Bristol Myers Squibb

November 22, 2020

Schrödinger, Inc. Reports Third Quarter 2020 Financial Results and Business Update

November 11, 2020

Schrödinger to Present at Upcoming Investor Conferences

November 9, 2020

Schrödinger to Present Data from Its MALT1 Inhibitor Program at the American Society of Hematology (ASH) 2020 Annual Meeting

November 4, 2020

Schrödinger to Host Third Quarter 2020 Financial Results Conference Call and Webcast

November 4, 2020

Schrödinger to Present at the Morgan Stanley 18th Annual Global Healthcare Conference

September 7, 2020

Schrödinger Announces Closing of Public Offering

August 16, 2020

Schrödinger Announces Pricing of Public Offering

August 11, 2020

Schrödinger, Inc. Reports Second Quarter 2020 Financial Results and Business Updates

August 9, 2020

Schrödinger Announces Proposed Public Offering of Common Stock

August 9, 2020

Schrödinger to Host Second Quarter 2020 Financial Results Conference Call and Webcast

August 2, 2020

← Newer news releases · Older news releases →

Calls

The 5 newest of 21 calls. Every call is listed under its year.

Decks

The 5 newest of 21 decks. Every deck is listed under its year.